Galectin Therapeutics

GALTNASDAQ
$2.24
-0.12-5.08%
At Close: -
$2.24
00.00%
After Hours: Jul 12, 4:02 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$11.00
Consensus Price Target1
$11.00

want to know what
the Bulls & Bears Say?

Galectin Therapeutics (NASDAQ:GALT) Stock, Analyst Ratings, Price Targets, Forecasts

Galectin Therapeutics Inc has a consensus price target of $11 based on the ratings of 1 analysts. The high is $11 issued by HC Wainwright & Co. on April 9, 2024. The low is $11 issued by HC Wainwright & Co. on April 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 9, 2024, April 1, 2024, and August 15, 2023, respectively. With an average price target of $11 between HC Wainwright & Co., there's an implied 391.07% upside for Galectin Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Galectin Therapeutics

Buy NowGet Alert
04/09/2024Buy Now391.07%HC Wainwright & Co.
Ed Arce
→ $11ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now391.07%HC Wainwright & Co.
Ed Arce
→ $11ReiteratesBuy → BuyGet Alert
08/15/2023Buy Now391.07%HC Wainwright & Co.
Ed Arce
$11 → $11ReiteratesBuy → BuyGet Alert
05/17/2023Buy Now391.07%HC Wainwright & Co.
Ed Arce
→ $11ReiteratesBuy → BuyGet Alert
03/03/2023Buy Now391.07%HC Wainwright & Co.
Ed Arce
→ $11Reiterates → BuyGet Alert
05/17/2022Buy Now391.07%HC Wainwright & Co.
Ed Arce
$14 → $11MaintainsBuyGet Alert

FAQ

Q

What is the target price for Galectin Therapeutics (GALT) stock?

A

The latest price target for Galectin Therapeutics (NASDAQ:GALT) was reported by HC Wainwright & Co. on April 9, 2024. The analyst firm set a price target for $11.00 expecting GALT to rise to within 12 months (a possible 391.07% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Galectin Therapeutics (GALT)?

A

The latest analyst rating for Galectin Therapeutics (NASDAQ:GALT) was provided by HC Wainwright & Co., and Galectin Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Galectin Therapeutics (GALT)?

A

There is no last upgrade for Galectin Therapeutics

Q

When was the last downgrade for Galectin Therapeutics (GALT)?

A

There is no last downgrade for Galectin Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Galectin Therapeutics (GALT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Galectin Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Galectin Therapeutics was filed on April 9, 2024 so you should expect the next rating to be made available sometime around April 9, 2025.

Q

Is the Analyst Rating Galectin Therapeutics (GALT) correct?

A

While ratings are subjective and will change, the latest Galectin Therapeutics (GALT) rating was a reiterated with a price target of $11.00 to $11.00. The current price Galectin Therapeutics (GALT) is trading at is $2.24, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch